No Data
Topchoice Medical Co., Inc.'s (SHSE:600763) Stock Is Going Strong: Is the Market Following Fundamentals?
Open Source Securities' investment strategy for the pharmaceutical industry in 2025: The long-term industry trend has not changed, focusing on the sector stabilizing and rebounding.
At the current stage, the pharmaceutical policy tends to be stable, the rapidly growing unmet clinical needs under the background of aging, and the continuous improvement of enterprise innovation capabilities are long-term industry trends that have not changed; at the same time, with the macroeconomic improvement, it is expected that the growth rate of medical insurance income suppressing the pharmaceutical sector will gradually improve.
Capital Allocation Trends At Topchoice Medical (SHSE:600763) Aren't Ideal
Tongce Healthcare: Report for the Third Quarter of 2024 by Tongce Healthcare Co., Ltd.
Tongce Medical Co., Ltd. Third Quarter Report 2024
Topchoice Medical (600763.SH) released its performance for the first three quarters, with a net income of 0.498 billion yuan, a year-on-year decrease of 2.63%.
topchoice medical (600763.SH) disclosed the third quarter report for 2024, achieving revenue in the first three quarters of the year 22...
There Are Reasons To Feel Uneasy About Topchoice Medical's (SHSE:600763) Returns On Capital
No Data
